For example, TIM-3 is expressed in patients with solid tumors and leukemia [42, 62, 63]. The expression of LAG-3, TIM-3 and TIGIT in solid tumors and leukemia and their correlation with clinical outcomes are summarized in Table 2. Here, HAVCR2 is linked to leukemia.